Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Sep, 2019 | Pages:
70 | Publisher: Netscribes
Industry: Healthcare | Report Format: Electronic (PDF)
The Asia-Pacific self-monitoring blood glucose devices market is expected to expand at a CAGR of 6.34% during the 2019-2024 period, owing to technological breakthroughs, rising obesity, and the increasing prevalence of diabetes. Product Segment Insights: The testing strips segment is expected to hold the highest market share (81.64%) in 2019. Owing to the development of innovative testing strips, and a massive increase in the incidence of diabetes, this segment is expected to witness a high CAGR of 6.94% during the forecast period. The glucometers segment is expected to remain steady while generating 12% of the revenue in the Asia-Pacific market in 2019. Factors like the advantages of glucometers over regular monitoring methodologies and the production of a wide range of devices will drive this segment. However, variations in results due to external and physiological factors will lead to a comparatively low CAGR (4.95%) during the 2019-2024 period. End User Segment Insights: The shift of medical services to decentralized surroundings like patients’ homes and the development of portable and user-friendly blood glucose monitoring devices will enable the home settings segment to expand at a CAGR of 6.82% during the 2019-2024 period. The hospitals sector will generate almost 7% of the total market revenue by 2019, and is anticipated to expand at a CAGR of 4.78% during the forecast period. Country-wise Insights: China and India account for half of the total diabetic population in the Asia-Pacific region. Advanced medical facilities, awareness programs, and cost-effective treatments to tackle diabetes will transform this region into the fastest-growing SMBG devices market in the world. China is expected to expand at a CAGR of 6.62% during the forecast period, while healthcare initiatives and government programs in India will enable the market in the country to expand at a CAGR of 6.46%. Companies covered: • Wockhardt • Roche Holding • Abbott Laboratories • i-SENS • Terumo Medical
Table of Contents Chapter 1. Executive summary 1.1. Market scope and segmentation 1.2. Key questions answered in this study 1.3. Executive summary Chapter 2: Asia-Pacific self-monitoring blood glucose devices market - overview 2.1. Market definitions 2.2. Market overview - Historical market revenue (USD Bn) - Forecasted market revenue (USD Bn) - Country-wise market revenue (USD Bn) 2.3. Market trends 2.4. Market drivers 2.5. Market challenges 2.6. Value chain analysis 2.7. Porter’s five forces analysis Chapter 3: Asia-Pacific self-monitoring blood glucose devices market - based on products 3.1. Testing strips - Market overview - Forecasted market segment revenue (USD Bn) 3.2. Glucometers - Market overview - Forecasted market segment revenue (USD Bn) 3.3. ‘Others’ - Market overview - Forecasted market segment revenue (USD Bn) Chapter 4: Asia-Pacific self-monitoring blood glucose devices market - based on end users 4.1. Hospitals - Market overview - Forecasted market segment revenue (USD Bn) 4.2. Diagnostic centers and clinics - Market overview - Forecasted market segment revenue (USD Bn) 4.3. Home settings - Market overview - Forecasted market segment revenue (USD Bn) Chapter 5: India self-monitoring blood glucose devices market 5.1. Overview - Revenue (USD Bn) - Forecasted market revenue (USD Bn) 5.2. Trends 5.3. Drivers 5.4. Challenges 5.5. Market observations based on products - Key market observations - Forecasted market revenue (USD Bn) 5.6. Market observations based on end users - Key market observations - Forecasted market revenue (USD Bn) Chapter 6: China self-monitoring blood glucose devices market 6.1. Overview - Revenue (USD Bn) - Forecasted market revenue (USD Bn) 6.2. Trends 6.3. Drivers 6.4. Challenges 6.5. Market observations based on products - Key market observations - Forecasted market revenue (USD Bn) 6.6. Market observations based on end users - Key market observations - Forecasted market revenue (USD Bn) Chapter 7: Australia and New Zealand self-monitoring blood glucose devices market 7.1. Overview - Revenue (USD Bn) - Forecasted market revenue (USD Bn) 7.2. Trends 7.3. Drivers 7.4. Challenges 7.5. Market observations based on products - Key market observations - Forecasted market revenue (USD Bn) 7.6. Market observations based on end-users - Key market observations - Forecasted market revenue (USD Bn) Chapter 8: Rest of Asia-Pacific self-monitoring blood glucose devices market 8.1. Overview - Revenue (USD Bn) - Forecasted market revenue (USD Bn) 8.2. Trends 8.3. Drivers 8.4. Challenges 8.5. Market observations based on products - Key market observations - Forecasted market revenue (USD Bn) 8.6. Market observations based on end-users - Key market observations - Forecasted market revenue (USD Bn) Chapter 9: Competitive landscape 9.1. Wockhardt* - Company snapshot - Products - Strategic initiatives - Countries present - Key people 9.2. Roche Holding 9.3. Abbott Laboratories 9.4. i-SENS 9.5. Terumo Medical (*) The coverage approach remains the same for all companies Chapter 10: Conclusion 10.1. PESTEL analysis 10.2. Impact assessment 10.3. Future outlook Chapter 11: Appendix 11.1. List of tables 11.2. Assumptions 11.3. Research methodology 11.4. About Research on Global Markets 11.5. Disclaimer
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
